RT Book, Section
A1 Rollins, Douglas E.
A1 Blumenthal, Donald K.
SR Print(0)
ID 1140226452
T1 Cancer Chemotherapy and Cytotoxic Agents
T2 Workbook and Casebook for Goodman and Gilman's The Pharmacological Basis of Therapeutics
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9780071793360-qa
LK accesspharmacy.mhmedical.com/content.aspx?aid=1140226452
RD 2024/04/18
AB Table  Graphic  Jump  Location|Download  (.pdf)|PrintTable  45-3.  AntimetabolitesTYPE  OF  AGENTNONPROPRIETARY  NAMESDISEASEFolic  acid  analogsMethotrexate  (amethopterin)Acute  lymphocytic  leukemia;  choriocarcinoma;  breast,  head,  neck  and  lung  cancers;  osteogenic  sarcoma;  bladder  cancerPemetrexedMesothelioma,  lung  cancerPyrimidine  analogsFluorouracil  (5-fluorouracil;  5-FU),  capecitabineBreast,  colon,  esophageal,  stomach,  pancreas,  head  and  neck;  premalignant  skin  lesion  (topical)Cytarabine  (cytosine  arabinoside)Acute  myelogenous  and  acute  lymphocytic  leukemia;  non-Hodgkin’s  lymphomaGemcitabinePancreatic,  ovarian,  lung  cancer5-aza-cytidineMyelodysplasiaDeoxy-5-aza-cytidineMyelodysplasiaPurine  analogs  and  related  inhibitorsMercaptopurine  (6-mercaptopurine;  6-MP)Acute  lymphocytic  and  myelogenous  leukemia;  small  cell  non-Hodgkin’s  lymphomaPentostatin  (2’-deoxycoformycin)Hairy  cell  leukemia;  chronic  lymphocytic  leukemia;  small  cell  non-Hodgkin’s  lymphomaFludarabineChronic  lymphocytic  leukemiaClofarabineAcute  myelogenous  leukemiaNelarabineT-cell  leukemia,  lymphoma